Bourne Research, the successful market research firm, have praised the direction of MEMS and Nanotech in providing real solutions to manage diabetes.
The company said that 2006 has seen an upswing in activity focusing on developing MEMS (MicroElectroMechanicalSystems) and nanotechnology-based solutions for the management and care of diabetes. The current cutting edge includes wireless and implantable technologies.
According to Bourne, a host of MEMS devices, nanostructures and other new technology could aid insulin delivery and blood glucose monitoring, as well as helping complications caused by diabetes.
Marlene Bourne, the President and principal analyst of Bourne Research, stated that: “What’s most notable about the current round of products in development, in clinical trials, or recently approved by the FDA and launched into the market is that many are wireless, implantable or both. While these approaches will make living with and managing diabetes much easier, they are also highlighting a very real need for next-generation battery technologies, which are in development.”
The emergent technology segment of the diabetes market is traditionally at the forefront of acquisition activity from the larger firms that dominate the diabetes market. An acquisition by one of the larger companies is expected shortly, perhaps pushing this technology away from a niche into the mainstream.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…